Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human Remove Human filter Veterinary Remove Veterinary filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Orphan designations Remove Orphan designations filter Summaries of opinion (26) Apply Summaries of opinion filter Withdrawn applications (51) Apply Withdrawn applications filter Paediatric investigation plans (200) Apply Paediatric investigation plans filter Referrals (17) Apply Referrals filter Direct healthcare professional communication (5) Apply Direct healthcare professional communication filter

Product number

Patient safety

Yes (6) Apply Yes filter

Authorisation status

Authorised (384) Apply Authorised filter Refused (16) Apply Refused filter Withdrawn (42) Apply Withdrawn filter

ATC code

Species

Marketing authorisation date

From:

To:

Marketing authorisation holder

Pharmacotherapeutic group

Date of opinion

From:

To:

Orphan disease / condition

Decision date

From:

To:

Orphan decision number

Orphan designation status

Positive (204) Apply Positive filter Withdrawn (1) Apply Withdrawn filter

Medicine type

Accelerated assessment Remove Accelerated assessment filter Additional monitoring Remove Additional monitoring filter Biosimilar Remove Biosimilar filter Conditional approval Remove Conditional approval filter Orphan medicine Remove Orphan medicine filter Exceptional circumstances (57) Apply Exceptional circumstances filter Generic (269) Apply Generic filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

647 results

Remove all filtersRemove all filters

Medicine European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Orphan designations Remove Orphan designations filter

Categories Human Remove Human filter Veterinary Remove Veterinary filter

Medicine type Accelerated assessment Remove Accelerated assessment filter Additional monitoring Remove Additional monitoring filter Orphan medicine Remove Orphan medicine filter Conditional approval Remove Conditional approval filter Biosimilar Remove Biosimilar filter

Sort by

List item

Human medicine European public assessment report (EPAR): Herzuma (updated)

trastuzumab, Stomach Neoplasms, Breast Neoplasms
Date of authorisation: 08/02/2018, , , Revision: 9, Authorised, Last updated: 26/10/2020
List item

Human medicine European public assessment report (EPAR): Zeposia (updated)

ozanimod hydrochloride, Multiple Sclerosis, Relapsing-Remitting
Date of authorisation: 20/05/2020, , Authorised, Last updated: 26/10/2020
List item

Human medicine European public assessment report (EPAR): Kalydeco (updated)

ivacaftor, Cystic Fibrosis
Date of authorisation: 23/07/2012, , , Revision: 25, Authorised, Last updated: 26/10/2020
List item

Human medicine European public assessment report (EPAR): Sixmo (updated)

Buprenorphine hydrochloride, Opioid-Related Disorders
Date of authorisation: 19/06/2019, , Revision: 1, Authorised, Last updated: 23/10/2020
List item

Human medicine European public assessment report (EPAR): Beovu (updated)

brolucizumab, Wet Macular Degeneration
Date of authorisation: 13/02/2020, , Revision: 1, Authorised, Last updated: 22/10/2020
List item

Human medicine European public assessment report (EPAR): Briviact (in Italy: Nubriveo) (updated)

Brivaracetam, Epilepsy
Date of authorisation: 13/01/2016, , Revision: 9, Authorised, Last updated: 22/10/2020
List item

Human medicine European public assessment report (EPAR): Glyxambi (updated)

empagliflozin, linagliptin, Diabetes Mellitus, Type 2
Date of authorisation: 11/11/2016, , Revision: 10, Authorised, Last updated: 22/10/2020
List item

Human medicine European public assessment report (EPAR): Sunosi (updated)

solriamfetol hydrochloride, Narcolepsy, Sleep Apnea, Obstructive
Date of authorisation: 16/01/2020, , Revision: 1, Authorised, Last updated: 22/10/2020
List item

Human medicine European public assessment report (EPAR): Synjardy (updated)

empagliflozin, metformin, Diabetes Mellitus, Type 2
Date of authorisation: 27/05/2015, , Revision: 17, Authorised, Last updated: 21/10/2020
List item

Human medicine European public assessment report (EPAR): SomaKit TOC (updated)

edotreotide, Neuroendocrine Tumors, Radionuclide Imaging
Date of authorisation: 08/12/2016, , , Revision: 6, Authorised, Last updated: 20/10/2020
List item

Human medicine European public assessment report (EPAR): Skyrizi (updated)

Risankizumab, Psoriasis
Date of authorisation: 26/04/2019, , Revision: 3, Authorised, Last updated: 20/10/2020
List item

Human medicine European public assessment report (EPAR): Viekirax (updated)

Ombitasvir, paritaprevir, ritonavir, Hepatitis C, Chronic
Date of authorisation: 14/01/2015, , , Revision: 21, Authorised, Last updated: 20/10/2020
List item

Human medicine European public assessment report (EPAR): Naglazyme (updated)

galsulfase, Mucopolysaccharidosis VI
Date of authorisation: 23/01/2006, , , Revision: 17, Authorised, Last updated: 20/10/2020
List item

Human medicine European public assessment report (EPAR): Obizur (updated)

susoctocog alfa, Hemophilia A
Date of authorisation: 11/11/2015, , , Revision: 5, Authorised, Last updated: 20/10/2020
List item

Human medicine European public assessment report (EPAR): Tevagrastim (updated)

filgrastim, Neutropenia, Hematopoietic Stem Cell Transplantation, Cancer
Date of authorisation: 15/09/2008, , Revision: 13, Authorised, Last updated: 19/10/2020
List item

Human medicine European public assessment report (EPAR): Fulphila (updated)

pegfilgrastim, Neutropenia
Date of authorisation: 20/11/2018, , , Revision: 5, Authorised, Last updated: 19/10/2020
List item

Human medicine European public assessment report (EPAR): Ratiograstim (updated)

filgrastim, Neutropenia, Hematopoietic Stem Cell Transplantation, Cancer
Date of authorisation: 15/09/2008, , Revision: 12, Authorised, Last updated: 19/10/2020
List item

Human medicine European public assessment report (EPAR): Xeljanz (updated)

tofacitinib citrate, Arthritis, Rheumatoid
Date of authorisation: 21/03/2017,
Date of refusal: 25/04/2013, , , Revision: 13, Authorised, Last updated: 19/10/2020
List item

Human medicine European public assessment report (EPAR): Jivi (updated)

Damoctocog alfa pegol, Hemophilia A
Date of authorisation: 22/11/2018, , Revision: 2, Authorised, Last updated: 19/10/2020
List item

Human medicine European public assessment report (EPAR): VeraSeal (updated)

human fibrinogen, human thrombin, Hemostasis, Surgical
Date of authorisation: 10/11/2017, , Revision: 3, Authorised, Last updated: 19/10/2020
List item

Human medicine European public assessment report (EPAR): Juluca (updated)

dolutegravir sodium, rilpivirine hydrochloride, HIV Infections
Date of authorisation: 16/05/2018, , Revision: 5, Authorised, Last updated: 19/10/2020
List item

Human medicine European public assessment report (EPAR): Libtayo (updated)

Cemiplimab, Carcinoma, Squamous Cell
Date of authorisation: 28/06/2019, , , Revision: 4, Authorised, Last updated: 19/10/2020
List item

Human medicine European public assessment report (EPAR): Mysimba (updated)

bupropion hydrochloride, naltrexone hydrochloride, Obesity, Overweight
Date of authorisation: 26/03/2015, , Revision: 16, Authorised, Last updated: 19/10/2020
List item

Human medicine European public assessment report (EPAR): Mayzent (updated)

Siponimod fumaric acid, Multiple Sclerosis, Relapsing-Remitting
Date of authorisation: 13/01/2020, , Revision: 3, Authorised, Last updated: 19/10/2020
List item

Human medicine European public assessment report (EPAR): Tecentriq (updated)

atezolizumab, Carcinoma, Transitional Cell, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 20/09/2017, , Revision: 11, Authorised, Last updated: 19/10/2020